Immucor specializes in transfusion and transplantation diagnostics, providing a comprehensive range of products designed to ensure donor-recipient compatibility and enhance laboratory efficiency. Their offerings include serology-based reagents, instruments, and molecular products that facilitate accurate pre-transfusion testing. Notably, Immucor's patented Capture® solid phase technology allows for a broad test menu and proven reliability, while their automation solutions enable laboratories to achieve fast turnaround times and high throughput. The company also emphasizes the importance of customized testing algorithms, particularly in their platelet portfolio, to meet the unique needs of different laboratories and patient populations.

In addition to transfusion diagnostics, Immucor offers advanced solutions for HLA typing and antibody detection, which are critical for safe blood transfusions and successful organ transplants. Their HLA donor screening assays provide reliable and cost-effective screening options, while their antibody detection products ensure clear and interpretable results. Immucor's commitment to innovation is further reflected in their continuous development of specialty reagents for complex investigations, making them a leader in the field. The company also prioritizes customer support and education, providing resources such as competency testing kits and technical assistance to enhance laboratory operations and improve patient outcomes.

United States

Immucor is a Georgia-based healthcare technology company that develops transfusion and transplantation diagnostic equipment for hospitals and clinical laboratories.

Immucor

Company Details